Author:
Kuznik Andreas,Iliyasu Garba,Habib Abdulrazaq G.,Musa Baba M.,Kambugu Andrew,Lamorde Mohammed
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference32 articles.
1. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience;Loubiere;Antivir Ther,2008
2. Cost-effectiveness of highly active antiretroviral therapy in South Africa;Badri;PLoS Med,2006
3. Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda;Sempa;BMC Public Health,2012
4. Earlier initialization of highly active antiretroviral therapy is associated with long-term survival and is cost-effective: findings from a deterministic model of a 10-year Ugandan cohort;Mills;J Acquir Immune Defic Syndr,2012
5. Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world;Vijayaraghavan;J Acquir Immune Defic Syndr,2007
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献